Góchez Delfy, Raicek Margot, Pinto Ferreira Jorge, Jeannin Morgan, Moulin Gerard, Erlacher-Vindel Elisabeth
Antimicrobial Resistance and Veterinary Products Department, World Organisation for Animal Health (OIE), Paris, France.
Agence nationale de Sécurité Sanitaire, Alimentation, Environnement, Travail (ANSES), Fougères, France.
Front Vet Sci. 2019 Sep 25;6:317. doi: 10.3389/fvets.2019.00317. eCollection 2019.
For over two decades, the World Organisation for Animal Health (OIE) has engaged in combatting antimicrobial resistance (AMR) through a One Health approach. Monitoring of antimicrobial use (AMU) is an important source of information that together with surveillance of AMR can be used for the assessment and management of risks related to AMR. In the framework of the Global Action Plan on AMR, the OIE has built a global database on antimicrobial agents intended for use in animals, supported by the Tripartite (World Health Organization (WHO), Food and Agriculture Organization of the United Nations (FAO) and OIE) collaboration. The OIE launched its first annual data collection in 2015 and published the Report in 2016. The second Report, published in 2017, introduced a new methodology to report quantitative data in the context of relevant animal populations, and included for the first time an annual analysis of antimicrobial quantities adjusted for animal biomass on a global and regional level. A continuing annual increase of countries participating in the data collection demonstrates the countries engagement for the global development of monitoring and surveillance systems in line with OIE international standards. Where countries are not yet able to contribute their quantitative data, their reports also highlight the barriers that impede them in data collection, analysis and/or reporting. The OIE Reports show annual global and regional estimates of antimicrobial agents intended for use in animals adjusted for animal biomass, as represented by the quantitative data reported by countries to the OIE. The OIE advises caution in interpretation of estimates made in the first few years of reporting recognizing some important limitations faced by countries as they develop their monitoring systems. The OIE remains strongly committed to supporting its Members in developing robust and transparent measurement and reporting mechanisms for AMU.
二十多年来,世界动物卫生组织(OIE)一直通过“同一个健康”方法参与抗击抗菌药物耐药性(AMR)工作。抗菌药物使用情况(AMU)监测是一项重要的信息来源,与AMR监测一起可用于评估和管理与AMR相关的风险。在《AMR全球行动计划》框架内,OIE建立了一个关于拟用于动物的抗菌药物的全球数据库,该数据库由三方(世界卫生组织(WHO)、联合国粮食及农业组织(FAO)和OIE)合作提供支持。OIE于2015年首次开展年度数据收集工作,并于2016年发布了报告。2017年发布的第二份报告引入了一种新方法,用于在相关动物种群背景下报告定量数据,并首次在全球和区域层面纳入了根据动物生物量调整后的抗菌药物数量年度分析。参与数据收集的国家数量持续逐年增加,这表明各国致力于按照OIE国际标准在全球范围内发展监测和监督系统。对于尚未能够提供定量数据的国家,其报告也突出了阻碍它们进行数据收集、分析和/或报告的障碍。OIE报告展示了根据各国向OIE报告的定量数据所调整的、以动物生物量为代表的拟用于动物的抗菌药物的年度全球和区域估计数。OIE建议在解读报告最初几年所做的估计时要谨慎,因为认识到各国在发展其监测系统时面临一些重要限制。OIE仍然坚定致力于支持其成员建立健全且透明的AMU测量和报告机制。